Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of the Safety and Efficacy of the Product Bepantol® Derma Spray After the Dermatological Procedure in the Face - 21 Days of Follow-up.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03853538
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:47.545223+00:00
Published At
2020-03-09T00:00:00+00:00
Record Updated At
2020-03-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Erythema", "Skin Recovery"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-03-09"
protocolSection.identificationModule.nctId
"NCT03853538"
protocolSection.identificationModule.officialTitle
"Evaluation of the Safety and Efficacy of the Product Bepantol\u00ae Derma Spray After the Dermatological Procedure in the Face - 21 Days of Follow-up."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Erythema (protocolSection.conditionsModule.conditions)
  • Skin Recovery (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.